| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 12, 2007
From Clinical Neurosciences (S.M.M., V.C., P.A.A., J.M.W.), and Medical Physics (I.M., M.E.B.), University of Edinburgh, Western General Hospital, Edinburgh, UK. * To whom correspondence should be addressed. E-mail: s.m.maniega{at}ed.ac.uk.
Background and Purpose—Choline and creatine are commonly used as denominators for other metabolites in ischemic stroke spectroscopy, assuming that they do not change. We investigated their concentration variation over time after stroke. Methods—Choline and creatine concentrations were measured by proton MR spectroscopic imaging in 51 patients at 5 times up to 3 months after stroke. Results—Choline and creatine levels changed significantly in the ischemic region. Choline was significantly reduced during the first 2 weeks after stroke onset (P=0.034). Creatine was significantly reduced during the whole period of the study (P=0.011). Conclusion—Choline and creatine concentrations are not reliable denominators for metabolite ratios in acute stroke because their levels vary significantly in ischemic brain regions.
Revised on January 4, 2008
Accepted on January 30, 2008
Choline and Creatine Are Not Reliable Denominators for Calculating Metabolite Ratios in Acute Ischemic Stroke
Susana Muñoz Maniega PhD*;
This article has been cited by other articles:
![]() |
B. Karaszewski, J. M. Wardlaw, I. Marshall, V. Cvoro, K. Wartolowska, K. Haga, P. A. Armitage, M. E. Bastin, and M. S. Dennis Early brain temperature elevation and anaerobic metabolism in human acute ischaemic stroke Brain, April 3, 2009; (2009) awp010v1. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |